Targeting prostate cancer for focal destruction

With an increasing number of men diagnosed with low‐risk prostate cancer because of prostate‐specific antigen screening, there is growing focus on avoiding overtreatment by radical surgery or radiation. While focal destruction of prostate cancer is an appealing concept, it remains unclear whether current diagnostic tools provide an adequate ability to map cancer for focal destruction. Candidate selection and improvements in diagnostic tools are essential prior to implemention of focal therapy.